Interrelationships among induction of cytochrome P-450 (CYP) 1A1/2, decrease in connexin 32 (Cx32), and liver tumor-promoting activity by &beta;-naphthoflavone (BNF) in the promotion stage were examined in a 2-stage liver carcinogenesis model. A total of 20 male Fischer 344 rats were initiated with a single intraperitoneal injection of 150 mg/kg of diethylnitrosamine (DEN) or were given the saline vehicle alone. Starting 2 weeks later, they were fed a diet containing 2%, 1%, or 0% BNF for 6 weeks. All animals were subjected to a two-thirds partial hepatectomy at week 3 and were sacrificed at week 8. Absolute and relative liver weights were significantly increased in the DEN+BNF groups as compared to the DEN-alone group. Diffuse hepatocellular hypertrophy with cytoplasmic eosinophilia, sometimes accompanied by development of adenoma-like hepatic foci, was observed in the BNF-treated rats. Remarkable induction of cytochrome CYP 1A1/2 and significant increase in CYP 2E1 were noted in the DEN+BNF groups, and positive immunohistochemical staining for both was observed diffusely. The areas of Cx32-positive spots per hepatocyte in the centrilobular areas of livers of the BNF-treated rats were significantly decreased, but no changes were observed in periportal areas. The numbers and areas of foci positive for glutathione S-transferase placental form were increased in the BNF-treated groups. These results suggest that BNF is a liver tumor promoter that, unlike phenobarbital, does not induce CYP 2B1/2 isozymes, and there seems to be no direct relationship between CYP 1A1/2 induction and Cx32 reduction in BNF hepatocarcinogenesis.
INTRODUCTION
(3-Naphthoflavone (BNF; 5,6-benzoflavone), a synthetic derivative of a naturally occurring flavonoid compound, strongly induces cytochrome P-450 (CYP) 1 A 1 / 2 and has different effects on other members of the monooxygenase system. Therefore, the discovery of inducing properties of BNF on the cytochrome P-450-dependent monooxygenase system has led to extensive examination of BNF as a modifier of chemical carcinogenesis (4) . Regarding CYP induction, BNF is similar in potency and specificity to the carcinogenic polycyclic aromatic hydrocarbons, such as 3-methylcholanthrene and benzo[a]pyrene. However, unlike these chemicals, BNF is generally regarded as noncarcinogenic (14) based on a literature search showing that BNF was not mutagenic (2) , although no definitive carcinogenicity study has been conducted.
A close association has been reported recently between the ability of chemicals such as phenobarbital to induce the CYP 2B 1/2 isozymes and their potential to promote hepatocarcinogenesis (5, 13) . In addition, it has been demonstrated that various types of liver tumor-promoting agents inhibit gap junctional intercellular communication (GJIC) in the rat liver in vivo (11) . Phenobarbital, for example, reversibly decreases the abundance of the GJIC protein connexin 32 (Cx32) in both altered hepatocellular foci (16) and centrilobular hepatocytes where CYP 2B1/ 2 isozymes are induced (15) . Based on the available data, it has been suggested that agents inducing CYP 2B 1/2 isozymes and reducing Cx32 in centrilobular hepatocytes are likely to be liver tumor promoters (15) .
In a recent study, fenbendazole (methyl 5-(phenylthio)-2-benzimidazole carbamate), a benzimidazole derivative and broad-spectrum anthelminthic veterinary drug, was reported to have liver tumor-promoting activity in a 2stage rat liver carcinogenesis model. This activity was associated with strong induction of CYP 2B 1 and CYP lA2 and with reduction of Cx32 in centrilobular areas (22) . However, whether the CYP lA2 elevation was actually correlated with liver tumor-promoting activity was unclear. To answer this question, it is necessary to investigate whether agents causing induction of members of CYP 1A subfamily but not CYP 2B have liver tumorpromoting activity and whether they reduce the abundance of Cx32 protein.
BNF is a nongenotoxic strong CYP lAl/2 inducer that does not appear to target CYP 2B subfamilies. In the present short-term study, relationships among its effects on CYP lAl/2 induction, Cx32 expression, and liver tumor development in the promotion stage were investigated in a 2-stage rat liver carcinogenesis model, which is widely used for rapid detection of hepatocarcinogenic agents (9) . For this purpose, levels of P-450 isozymes, GJIC, and foci of altered hepatocytes positive for gluta- thione S-transferase placental form (GST-P), a reliable marker enzyme for preneoplastic lesions in rat hepatocarcinogenesis (9), were examined.
MATERIALS AND METHODS
Animal Experiment. Male Fischer 344 rats were obtained at 5 weeks of age (Charles River Japan Inc, Atsugi, Japan) and housed 5 to a polycarbonate cage with wooden chips as bedding in an air-conditioned animal room (23°C ± 2°C, 60% -~-5°/o relative humidity, 12-hour light/ 12-hour dark cycle). Animals without any abnormal findings after a 2-week acclimatization period were selected FIGURE Livers of rats given diets containing 0% (a) or 2% (b) BNF for 6 weeks after DEN initiation. As compared with the control animal (a), diffuse hepatocellular hypertrophy with cytoplasmic eosinophilia is apparent with DEN+BNF (b). H&E.
for the present study. Powdered basal diet (CRF-1, Oriental Yeast Co Ltd, Tokyo, Japan) and distilled water were provided ad libitum. BNF (purity >98%) and diethylnitrosamine (DEN) were obtained from Wako Pure Chemical Industries Ltd, Osaka, Japan).
A total of 20 rats were divided into 4 groups of 5 animals each. Animals in groups 1-3 were initiated with a single intraperitoneal injection of DEN (150 mg/kg), and animals in group 4 (control) received a single intraperitoneal injection of saline vehicle alone. Two weeks later, animals in groups 1-3 were given diets containing FIGURE 2.-Liver of rat given a diet containing 2% BNF for 6 weeks after DEN initiation. An adenoma-like hepatic eosinophilic cell focus features large pale eosinophilic hepatocytes with cellular. and nuclear atypia, apoptotic figures, and compression of adjacent hepatic cords.
H&E. X 120. I BNF for 6 weeks at the following concentrations: group 1 (DEN+BNF 2%), 2%; group 2 (DEN+BNF 1 %), 1 %; and group 3 (DEN alone), 0%. Diets were renewed once weekly, and the BNF was mixed in the diet according to a standard operating procedure manual to maintain the concentration of BNF at 1 % or 2%. BNF has been confirmed by the manufacturer to be stable at room temperature for at least 6 months; therefore, no degradation of BNF in the diet was expected during the study. All animals were subjected to a two-thirds partial hepatectomy at week 3 and then euthanized at week 8 by exsangui- CYP 2E1 (b) in livers of rats given a diet containing 2% BNF for 6 weeks after DEN initiation. CYP lAl/2 and CYP 2E are diffusely stained in hepatocytes throughout the lobes. LSAB method, hematoxylin counterstain. X 150. nation from the abdominal aorta under ether anesthesia after measurement of body weight. In another study (unz published data) in which rats were fed 1 % BNF for 26 weeks after partial hepatectomy with or without DEN i initiation, no proliferative liver lesions (foci and adeno-J mas) were observed in the group without DEN initiation.
However, in the DEN+BNF group, the incidence of hepatocellular adenomas was significantly higher than that in the DEN-alone group. Therefore, BNF was considered < a liver tumor promoter rather than a genotoxic carcino- gen, and a group administered BNF alone was not included in the present study. The animals were necropsied, and the livers excised and their weights recorded. Because the animals had been subjected to a partial hepatectomy (left and median lobes excised), the remaining liver consisted of the anterior and posterior right and caudate lobes. About half of the anterior and posterior right lobes and all of the caudate lobe were frozen immediately by immersion in liquid nitrogen for subsequent western blotting of P-450 isozymes and Cx32 immunohistochemistry. The remaining parts of the anterior and posterior right lobes were fixed in 10% neutral buffered formalin for light microscopy. All animals were handled in accordance with the Guidelines for Animal Experimentation of the Japanese Association for Laboratory Animal Science.
Light Microscopy. The fixed liver tissue from each animal was cut into 4 slices, embedded in paraffin, sectioned at 4 [Lm, and stained with hematoxylin and eosin (H&E) for microscopic examination. Western Blot Analysis of Cytochrome P-450 Isozymes. After 6 weeks of BNF treatment, the frozen livers from all animals were homogenized in 3 volumes of 1.15% KCI, followed by differential centrifugation and resuspension of microsome fractions in 1.15% KCI/20% glycerol. Microsomal protein of each liver sample, including the control sample, which were bound to the antibodies against CYP isozymes, were adjusted to the same concentration (2 mg/ml) by 1.15% KCI. Subsequently, microsomal proteins of each sample, including the control sample in which the amount of each CYP per milligram of protein had already been measured by the antibody manufacturer, were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis on 7.5% polyacrylamide gels according to the method of Laemmli (12) and electrophoretically transferred to polyvinylidene difluoride membranes. These membranes were incubated with goat anti-rat CYP 1 A 1 /2, 2B 1 /2, 2E 1, 3A2, or 4A (1: 2,000; Daiichi Pure Chemicals Co Ltd, Tokyo, Japan) for 60 minutes followed by peroxidase-labeled rabbit antigoat IgG (H + L) (1:4,000; BioMakor bm, Rehovot, Israel) for 30 minutes. Binding was visualized with a horseradish-peroxidase conjugate substrate kit (Bio-Rad, Hercules, CA, USA). Specific contents of each cytochrome P-450 isozyme were quantified with densitometry using NIH Image software (National Institutes of Health, Washington, DC, USA) by relative comparison with the control samples. The specificities of each anti-CYP isozyme antibody were reported previously (8) .
Immunohistochemistry of P-450 Isozymes. Formalinfixed, paraffin-embedded liver tissue was sectioned at 4 (JLm and stained immunohistochemically using the labeled streptavidin-biotin-peroxidase complex (LSAB) method for binding of goat anti-rat CYP lAl/2 and CYP 2E1 (1: 100; Daiichi Pure Chemicals) as primary antibodies. All specimens were lightly counterstained with hematoxylin. Cx32 Immunohistochemistry. Frozen liver slices from DEN-initiated groups after 6 weeks of BNF treatment were sectioned at 5 jjun in a cryostat for Cx32 immunohistochemical staining. The sections were fixed in acetone at -20°C, dried, and successively incubated with mouse anti-rat Cx32 monoclonal antibody (1:1,000; Pharmacological Laboratory, Nippon-Shinyaku, Kyoto, Japan) for 1 hour (23), biotinylated rabbit anti-mouse immunoglobulins (1:200; DAKO A/S, Glostrup, Denmark) for 1 hour, and fluorescent streptavidin (1:30; Vector Laboratories, Burlingame, CA, USA) for 30 minutes in the dark. Mounted slides were examined under a light microscope equipped for fluorescence, and 10 high-magnification ( X 66) micrographs (5 each for centrilobular and periportal areas) were taken per animal. The numbers and areas of Cx32-positive spots per cell in centrilobular and periportal areas were then measured with the aid of an IPAP image analyzer (Sumika Technoservice, Osaka, Japan). GST-P Immunohistochemistry. Immunohistochemical staining using polyclonal antibodies against GST-P was applied to allow quantitative evaluation of altered hepatocellular foci (19) . Formalin-fixed, paraffin-embedded liver tissue was sectioned at 4 jjbm and stained immunohistochemically using the LSAB method for binding of rabbit anti-rat GST-P polyclonal antibody ( 1:2,000; MBL, Nagoya, Japan). All specimens were lightly counterstained with hematoxylin. Numbers and areas of altered foci positive for GST-P (±3 hepatocytes in cross section) were measured using the IPAP image analyzer to generate number and area values per sqare centimeter. The GST-P immunohistochemistry revealed that BNF induced GST-P expression slightly and diffusely in small areas of hepatocytes without any clear zonal bias. However, these areas could easily be distinguished from the discrete foci of altered hepatocytes, which were strongly positive for GST P Statistical Analysis. Differences in quantitative data for body weights, liver weights, P-450 isozymes, Cx32positive spots and areas, and GST-P-positive foci were analyzed for significance using Dunnett's 2-tailed test.
RESULTS

Body and Liver Weights
No significant alteration in body weights was observed in the DEN+BNF groups ( Table 1 ). The absolute and relative liver weights (relative to body weight) were significantly increased in both DEN+BNF groups as compared with the DEN-alone group.
Light Microscopy
Light microscopically, diffuse hepatocellular hypertrophy with cytoplasmic eosinophilia was evident in the livers of the DEN+BNF groups (Figure la, b ). Altered hepatocellular foci, comprised mainly of eosinophilic or clear cells, were observed in the DEN-initiated groups.
In addition, a few larger eosinophilic cell foci [adenomas, based on the histopathologic criteria of Goodman et al (7) ] featuring large pale eosinophilic hepatocytes with cellular and nuclear atypia, mitosis, apoptotic figures, and compression of adjacent hepatic cords were observed in all animals in the DEN+BNF 2% group (Figure 2 ) and (Table 2 ). There was no remarkable induction of CYP 3A2 or CYP 2B2 ( Table 2 ). CYP 2B 1 was not detected in any of the groups. Immunohistochemically, CYP lAl/ 2 and CYP 2E1 were stained diffusely in both DEN+BNF groups (Figure 3a, b ). In the adenoma-like foci seen in the DEN+BNF groups, most large hepatocytes were positive for CYP 1 A 1 /2 and CYP 2E but some were negative (Figure 4a, b) . Cx32 Immunohistochemistry. In the livers of the animal receiving DEN alone, Cx32 spots were diffusely distributed on all hepatocytes (Table 3 and Figure 5a, b) . The areas of Cx32-positive spots per cell in the centrilobular areas were significantly reduced in the livers of both DEN+BNF groups (Figure 5c ). The numbers of Cx32-positive spots per cell in the centrilobular areas in the livers of the DEN+BNF 2% group were also slightly decreased, although the decrease was not significant.
There was no variation in the numbers and areas of Cx32positive spots per cell in periportal areas between the DEN+BNF and DEN-alone groups (Figure 5b, d ).
GST-P Immunohistochemistry. Foci positive for GST-P were observed diffusely without any clear zonal bias. The numbers and areas of GST-P-positive foci were significantly increased in the DEN+BNF groups as compared with the DEN-alone group (Table 4 ). There was no difference in the size of enzyme-altered foci between the DEN+BNF groups and the DEN-alone group.
DISCUSSION
It has been proposed that a link exists between the capacity of agents such as barbiturates to induce CYP 2B 1/2 and their ability to promote hepatocarcinogenesis (5, 13) , as exemplified by the phenobarbital example (15) . In contrast to its strong effects, the related barbiturates amobarbital, pentobarbital, and barbituric acid cause weak CYP 2B 1/2 induction and are relatively weak promoters of rat liver tumor development (6, 17, 20) . In a recent study, fenbendazole had liver tumor-promoting activity, strongly induced CYP lA2 and CYP 2B l, and 2-tailed test. reduced Cx32 in the centrilobular area (22) . The present study was performed to determine whether a compound inducing the CYP 1A subfamily but not the CYP 2B subfamily might also be a tumor promoter. CYP 1 A 1 /2 is known to be induced by polycyclic aromatic hydrocarbons (eg, 3-methylcholanthrene, benzo[a]pyrene) and polyhalogenated aromatic compounds (eg, 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3,3',4,4',5,5'hexachlorobiphenyl) , and many of these xenobiotics are mutagenic or carcinogenic in laboratory animals. BNF is a synthetic analogue of naturally occurring flavonoids, which are widely distributed among edible plants such as citrus fruits, vegetables, and tea. BNF showed no frameshift mutagenic activity when screened over a wide range of concentrations in several strains in the Salmonellal mammalian microsome assay (2) , and there have been no reports of BNF carcinogenicity (14) .
In the present study, BNF was chosen as a typical strong CYP lAl/2 but not CYP 2B1/2 inducer without mutagenic activity to assess the relationships among CYP IAI/2 induction, Cx32 expression, and tumor development. A clear increase in GST-P-positive altered foci was evidence of promotion activity by BNF along with induction of adenomas limited to the DEN+BNF groups (9) . Thus, there may be a link between CYP lAl/2 induction and liver tumor-promoting activity. Dioxin is a widespread polychlorinated aromatic hydrocarbon that causes tumors in the liver and other sites when administered chronically to rats. Dioxins bind to the aryl hydrocarbon (Ah) receptor, and the resultant Ah receptordioxin complexes interact with sites in regulatory regions of certain genes. These genes affect cell growth, cell differentiation, and metabolic processes, and the resulting modulation of gene expression is believed to be obligatory for both dioxin toxicity and carcinogenicity (1, 18) . However, Andersen et al (1) reported modeling of receptor-mediated processes to indicate that the induction of the CYP IA subfamily may not be causally related to tumor formation. Thus the mechanism of liver tumor promotion activity of dioxins still remains unclear. However, because BNF has been shown to be a ligand to the Ah receptor similar to dioxins, inducing CYP 1 A 1 /2 via the Ah receptor (3), the possibility that the liver tumor-promoting effect of BNF is mediated by the Ah receptor -FIGURE 5.-Cx32-positive spots in centrilobular (a, c) and periportal (b, d) hepatocytes of rats given diets containing 0% (a, b) or 2% (c, d) BNF for 6 weeks after DEN initiation. Note the remarkable decrease of positive spots in the centrilobular area (c) as compared with the DEN-alone group (a), but there is no remarkable change in the periportal area (b, d). Immunofluorescence staining. X240. should be taken into account as a hypothesis for the promoting mechanism.
GJIC is considered to be essential for maintaining tissue homeostasis and the cell growth control pathway, and its disruption is believed to play an important role in carcinogenesis (10) . In most rodent and human cancer cell lines, GJIC is prominently reduced (24) . In addition, a number of tumor-promoting agents inhibit GJIC in the rat liver in vivo (11) . Phenobarbital has been shown to reversibly decrease the abundance of the GJIC protein Cx32 in the centrilobular hepatocytes where CYP 2B 1/2 isozymes are induced, and therefore an association between the two parameters has been suggested (15) . However, these correlations exist only for CYP 2B 1/2, and the correlation with other CYP isozymes remains unclear. In the present study, although areas of Cx32-positive spots were significantly decreased in centrilobular hepatocytes of the DEN+BNF groups, similar to the results for phenobarbital (15) , CYP lAl/2 induction was observed diffusely. This lack of coincidence suggests that CYP lAl/ 2 induction and Cx32 inhibition may occur independently of each other. It is not clear from the present study whether induction of CYP 1A1/2 and reduction of gap junctions are causally linked or merely associated with the hepatocarcinogenic process, but there seems to be no direct correlation between them in BNF hepatocarcinogenesis. The evidence thus suggests that Cx32 disruption may be correlated with the promoting activity of BNE In a recent study, clofibrate, a peroxisome proliferator and well-known liver carcinogen, strongly induced CYP 4A1 in a diffuse pattern and CYP 2B 1/2 centrilobularly. However, Cx32 reduction was, again, seen only in centrilobular hepatocytes, leading to the conclusion that Cx32 reduction may be related to CYP 2B 1/2 induction but not CYP 4A induction (21) . Therefore, the induction of P-450 isozymes other than CYP 2B 1/2 may not be directly linked to inhibition of Cx32 protein.
Further studies are necessary to clarify the molecular mechanisms responsible for centrilobular alterations in Cx32, the diffuse induction of CYP lAl/2, and the relevance of these changes to hepatocarcinogenesis. BNFinduced changes in these parameters within hepatocyte foci also warrant attention.
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